injection: be administered in hypodermis

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents option
Weight: 0.58
, form
Weight: 0.55
, intervention
Weight: 0.54
, thing
Weight: 0.53
, time
Weight: 0.53
Siblings infusion
Weight: 0.59
, stock option
Weight: 0.32
, enema
Weight: 0.31
, liquid
Weight: 0.31

Related properties

Property Similarity
be administered in hypodermis 1.00
is administered 1.00
be frequently administered into hypodermis 0.91

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Salient implies Plausible

0.27
Rule weight: 0.28
Evidence weight: 0.95
Similarity weight: 1.00
Evidence: 0.91
Plausible(injection, be administered in hypodermis)
Evidence: 0.53
¬ Salient(injection, be administered in hypodermis)

Similarity expansion

0.84
Rule weight: 0.85
Evidence weight: 0.99
Similarity weight: 1.00
Evidence: 0.61
Typical(injection, be administered in hypodermis)
Evidence: 0.02
¬ Typical(injection, is administered)
0.80
Rule weight: 0.85
Evidence weight: 0.94
Similarity weight: 1.00
Evidence: 0.91
Plausible(injection, be administered in hypodermis)
Evidence: 0.61
¬ Plausible(injection, is administered)
0.71
Rule weight: 0.85
Evidence weight: 0.91
Similarity weight: 0.91
Evidence: 0.91
Plausible(injection, be administered in hypodermis)
Evidence: 0.97
¬ Plausible(injection, be frequently administered into hypodermis)
0.65
Rule weight: 0.85
Evidence weight: 0.77
Similarity weight: 1.00
Evidence: 0.53
Salient(injection, be administered in hypodermis)
Evidence: 0.49
¬ Salient(injection, is administered)
0.59
Rule weight: 0.85
Evidence weight: 0.76
Similarity weight: 0.91
Evidence: 0.38
Remarkable(injection, be administered in hypodermis)
Evidence: 0.38
¬ Remarkable(injection, be frequently administered into hypodermis)
0.52
Rule weight: 0.85
Evidence weight: 0.67
Similarity weight: 0.91
Evidence: 0.61
Typical(injection, be administered in hypodermis)
Evidence: 0.84
¬ Typical(injection, be frequently administered into hypodermis)
0.49
Rule weight: 0.85
Evidence weight: 0.64
Similarity weight: 0.91
Evidence: 0.53
Salient(injection, be administered in hypodermis)
Evidence: 0.77
¬ Salient(injection, be frequently administered into hypodermis)
0.35
Rule weight: 0.85
Evidence weight: 0.41
Similarity weight: 1.00
Evidence: 0.38
Remarkable(injection, be administered in hypodermis)
Evidence: 0.94
¬ Remarkable(injection, is administered)

Typical and Remarkable implies Salient

0.12
Rule weight: 0.14
Evidence weight: 0.89
Similarity weight: 1.00
Evidence: 0.53
Salient(injection, be administered in hypodermis)
Evidence: 0.61
¬ Typical(injection, be administered in hypodermis)
Evidence: 0.38
¬ Remarkable(injection, be administered in hypodermis)

Typical implies Plausible

0.45
Rule weight: 0.48
Evidence weight: 0.95
Similarity weight: 1.00
Evidence: 0.91
Plausible(injection, be administered in hypodermis)
Evidence: 0.61
¬ Typical(injection, be administered in hypodermis)